Long-term Chinese herbs decoction administration for management of hot flashes associated with endocrine therapy in breast cancer patients

Chinese Journal of Cancer Research

Volumn 23, Issue 1, 2011, Pages 74-78

  Xue, Dong ^a   Sun, Hong ^a   Li, Ping Ping ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Breast cancer; Chinese herbs decoction; Endocrine therapy; Hot flashes; Tamoxifen

Indexed keywords

AROMATASE INHIBITOR; CHINESE DRUG; PLANT MEDICINAL PRODUCT; SHU GAN LIANG XUE DECOCTION; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOT FLUSH; HUMAN; KUPPERMAN SCORING INDEX; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; SLEEP DISORDER;

EID: 79953203586     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-011-0074-7     Document Type: Article

References (43)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
2. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) Breast Cancer (Version 2.2010). ©2010 National Comprehensive Cancer Network, Inc. Available from: NCCN.org. Accessed December 1st 2010.
3. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351:1451-67.
4. Chang YC, Parker J, Dooley WC. Hot flash therapies in breast cancer survivors. Support Cancer Ther 2006; 4:38-48.
5. Carpenter JS, Johnson D, Wagner L, et al. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002; 29:E16-25.
6. Ashraf M, Biswas J, Majumdar S, et al. Tamoxifen use in Indian women - adverse effects revisited. Asian Pac J Cancer Prev 2009; 10:609-12.
7. Dorjgochoo T, Gu K, Kallianpur A, et al. Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study. Menopause 2009; 16:1205-12.
8. Kupperman HS, Blatt MHG, Wiesbader H, et al. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol 1953; 13:688-703.
9. Kupperman HS, Wetchler BB, Blatt MH. Contemporary therapy of the menopausal syndrome. J Am Med Assoc 1959; 171:1627-37.
10. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-97. (Pubitemid 41127293)
11. Zhang PY. Cessation administration of Tamxifen in breast cancer patients and analysis of TCM effect. Chin J Integrat Surg (in Chinese) 2005; 11:493-4.
12. Carpenter JS, Yu M, Wu J, et al. Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion. Menopause 2009; 16:644-52.
13. Henry NL, Rae JM, Li L, et al. Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort. Breast Cancer Res Treat. 2009; 117:571-5.
14. Mortimer JE, Flatt SW, Parker BA, et al. Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat 2008; 108:421-6. (Pubitemid 351431079)
15. Kligman L, Younus J. Management of hot flashes in women with breast cancer. Curr Oncol 2010; 17:81-6.
16. Hickey M, Saunders C, Partridge A, et al. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 2008; 19:1669-80.
17. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356:2059-63. (Pubitemid 32009821)
18. Loibl S, Schwedler K, von Minckwitz G, et al. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study. Ann Oncol 2007; 18:689-93. (Pubitemid 46523272)
19. Garber K. Tamoxifen pharmacogenetics moves closer to reality. J Natl Cancer Inst 2005; 97:412-3. (Pubitemid 40528597)
20. Jin Y, Desta Z, Stearns V, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005; 97:30-9.
21. Brauch H, Mürdter TE, Eichelbaum M, et al. Pharmacogenomics of tamoxifen therapy. Clin Chem 2009; 55:1770-82.
22. Debourdeau P, Bachelot T, Zammit C, et al. Treatment of hot flashes in women with a previous diagnosis of breast cancer. Bull Cancer. 2004; 91:339-49. (Pubitemid 38662063)
23. von Schoultz E, Rutqvist LE, Stockholm Breast Cancer Study Group. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 2005; 97:533-5. (Pubitemid 40590435)
24. Quella SK, Loprinzi CL, Sloan JA, et al. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer 1998; 82:1784-8. (Pubitemid 28208931)
25. Carpenter JS, Storniolo AM, Johns S, et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 2007; 12:124-35. (Pubitemid 46150798)
26. van Gool AR, Bannink M, Bontenbal M, et al. Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer. Neth J Med 2005; 63:175-8. (Pubitemid 40796686)
27. Bordeleau L, Pritchard KI, Loprinzi CL, et al. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 2010; 28:5147-52.
28. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 2002; 20:1449-55. (Pubitemid 34260522)
29. MacGregor CA, Canney PA, Patterson G, et al. A randomized double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer 2005; 41:708-14. (Pubitemid 40342553)
30. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001; 19:2739-45. (Pubitemid 32441380)
31. Elkins G, Marcus J, Stearns V, et al. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol 2008; 26:5022-6.
32. Pierce JP, Natarajan L, Caan BJ, et al. Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study. Am J Clin Nutr 2009; 89:1565S-71S.
33. Gold EB, Pierce JP, Natarajan L, et al. Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol 2009; 27:352-9.
34. Filshie J, Bolton T, Browne D, et al. Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients--audit and treatment algorithm. Acupunct Med 2005; 23:171-80. (Pubitemid 43097817)
35. Nedstrand E, Wijma K, Wyon Y, et al. Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 2005; 8:243-50. (Pubitemid 41226464)
36. Sun H, Li PP, Xie YT. Impact of Shu Gan Liang Xue decoction combined with tamoxifen on the growth and estrogen receptor expression in human breast cancer cell line MCF-7. China Cancer (in Chinese) 2005; 14:607-10.
37. Sun Y, Li PP. The Shuganliangxue decoction's effects on the metabolism of tamoxifen. Chin J Exp Tradition Med Formul (in Chinese) 2009; 15:76-9.
38. Sun Hong, Xue Dong, Gao Fei, et al. Effect of shugan liangxue compund for relieving hot flashes in breast cancer patients. Zhongguo Zhong Xi Yi Jie He Za Zhi (in Chinese) 2009; 29:30-3.
39. Loprinzi CL, Zahasky KM, Sloan JA, et al. Tamoxifen-induced hot flashes. Clin Breast Cancer 2000; 1:52-6.
40. Otte JL, Flockhart D, Hayes D, et al. Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy. Menopause 2009; 16:653-9.
41. Ganz PA, Desmond KA, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002; 94:39-49. (Pubitemid 34082842)
42. Ganz PA, Greendale GA, Petersen L, et al. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 2000; 92:1054-64. (Pubitemid 30618024)
43. Carpenter JS, Andrykowski MA, Cordova M, et al. Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 1998; 82:1682-91. (Pubitemid 28208918)